MDT - Acutus climbs 50% as company launches a broader range of cardiac devices

Acutus Medical (NASDAQ:AFIB) a medical device company focused on cardiac arrhythmias surged ~50% in the pre-market on the announcement of the commercial launch of an expanded suite of left-heart access products. Its product offering now includes the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAAC Device, Carlsbad, California-based company said. “The AcQCross system provides interventional cardiologists and electrophysiologists with unique benefits of broad compatibility with market-leading access sheaths while also enhancing procedure versatility and workflow,” interim Chief Executive of Acutus (AFIB) David Roman said. In April, the company shares surged after announcing an agreement with health equipment maker Medtronic (MDT) to sell its left-heart access portfolio for $50M of upfront cash and milestone-based payments.

For further details see:

Acutus climbs 50% as company launches a broader range of cardiac devices